Characterizing Protein Aggregation With Orthogonal and Complementary Analytical Techniques

Characterizing Protein Aggregation With Orthogonal and Complementary Analytical Techniques

Strategies for monitoring particles in biopharmaceutical formulations are essential in the development and manufacturing of safe, effective drug products. A central challenge with particle analysis in biotherapeutics is the wide size range of particles that may be present, including particles from the active pharmaceutical ingredient (API), as well as excipients and contaminants. These particles can be as small as a few nanometers (e.g., oligomer-sized protein aggregates, individual viruses), in the subvisible range (1-100 µm), or large enough to be seen by the unaided eye (e.g., visible API aggregates). While several analytical techniques exist for particle monitoring, each can only analyze particles within a finite size range. Characterizing the entire particle content of a biotherapeutic sample would require using several different complementary analytical techniques to cover the potentially broad size range of particles present.

Orthogonal and Complementary WP thumbnail
Download White Paper

In this white paper, we demonstrate how using a combination of orthogonal and complementary particle analysis techniques can give you a complete picture of the particles in your sample.

Orthogonal techniques measure the same quantities as another technique but are based on a different measurement principle, and are often necessary in order to confirm measurements and mitigate the limitations of each individual technique. While they can be time and sample-consuming, these multi-instrument particle monitoring strategies can provide a better understanding of a sample’s particle
characteristics than a single measurement alone.

We analyzed a protein formulation that was exposed to accelerated shaking and heat stress using four analytical techniques: subvisible flow imaging microscopy (FlowCam LO), light obscuration (FlowCam LO), submicron flow imaging microscopy (FlowCam Nano), and dynamic light scattering. Additionally, this study used these particle measurement techniques to investigate the impact of surfactants on protein aggregation by performing the shaking and heat stress both with and without the presence of polysorbate 80.

 

Post Topics

Related Posts

HTD Biosystems logo with a background of Bay Area scenery
Bay Area CDMO Offers FlowCam Analytical Services and Formulation Development
A conversation with HTD Biosystems HTD Biosystems provides services to accelerate the development of biotech drugs, liposomal drug delivery systems, …
Read Post
antibodies floating in space
Why is Protein Aggregate Analysis Important During Formulation Development?
The protein aggregate content in protein therapies and other biologic drug products is often a critical quality attribute that must be monitored. …
Read Post
Need Supplies?

Find supplies and spare parts for your FlowCam instrument or ask for a quote. 

Order Now

Need Help?

Get technical support and application help. Request training or preventative maintenance.


Submit a Support Ticket

Need Information?

Check out our knowledge base including white papers, application notes, technical notes, and videos.

View Resources